Primary care physician Eric Weil directs a program that shows that more attentive care for high-risk patients may be the most effective way to control costs.
From mishandled stolen shipments to repackaged fakes to scammers diluting medications, there are multiple ways phony pharmaceuticals get in the supply chain.
Trials that involve new drugs being compared to existing versions could let inferior treatments slip through.
The city’s first hospital was founded to treat the poor—and serve as a teaching locale for Harvard Medical School.
Douglas Farrago’s bimonthly collection of top-ten lists, editorials and “True Stories of Medicine” provides a sharp satire of the health care system.
A federal court recently ruled that they couldn’t, whereas supporters and critics continue to debate whether patents foster or hinder innovation.
Retail clinics brought grocery-aisle convenience to strep tests and flu shots. Now they’re aiming to manage chronic conditions.
It’s much easier to get a medical device approved than to bring a new drug to market. Should that change?
The world’s hospitals rely on technetium-99m for imaging, but the isotope is in short supply.
Does the recertification process prove physicians’ expertise or just waste their time?
No Articles Found.